Effect of haemodiafiltration versus haemodialysis on vascular access patency when starting haemodialysis
Nephrology Dialysis Transplantation · 2025
DOI: 10.1093/ndt/gfaf017 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Nephrology Dialysis Transplantation, 2025. Verfasst von Mahoko Yoshida und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Hiroshima University Hospital, Hiroshima, Japan. Hauptthemen laut MEDLINE: Renal Dialysis, Hemodiafiltration, Kidney Failure, Chronic, Vascular Patency. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
Background
Haemodiafiltration (HDF) therapy improves the prognosis by reducing inflammation and oxidative stress and improving endothelial function. These factors contribute to vascular access (VA) stenosis, one of the most common complications in patients on haemodialysis (HD) or HDF. This study aimed to assess the efficacy of HDF on VA patency.
Methods
This multicentre, prospective, observational study with post hoc analysis included 612 patients among 643 who underwent VA procedures and started dialysis between April 2012 and March 2021. A total of 516 patients were on HD since starting dialysis, while 96 switched to HDF after starting dialysis. One-to-one propensity score matching was performed to compare the 24-month patency rates of VA between groups by Kaplan–Meier and logrank tests, and a Cox proportional hazards regression analysis was used to identify factors affecting patency rates.
Results
There were 87 patients in each group. The 24-month primary patency rates were 74.2% for HDF and 47.7% for HD (P < .001). A multivariate Cox proportional hazards analysis showed that a history of cardiovascular disease {hazard ratio [HR] 2.29 [95% confidence interval (CI) 1.21–4.34], P = .01} and higher haemoglobin A1c values [HR 1.37 (95% CI 1.00–1.82), P = .04] were associated with poor 24-month primary patency. However, HDF [HR 0.30 (95% CI 0.16–0.56), P < .001] and use of statins [HR 0.50 (95% CI 0.27–0.94), P = .03] were associated with better patency. A stratified analysis showed that HRs for loss of VA patency were lower in patients with HDF than in those with HD in the subgroups of ≥65 years, male sex, radiocephalic arteriovenous fistula, a history of diabetes mellitus or cardiovascular disease, haemoglobin concentrations <10 g/dl and albumin concentrations <3.5 g/dl.
Conclusions
HDF potentially improves VA patency rates compared with HD, even in patients with cardiovascular disease or diabetes, commonly associated with poor patency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, Hiroshima University Hospital, Hiroshima, Japan.
ORCID-Profile: Mahoko Yoshida, Yujiro Maeoka
Zitieren
APA
Yoshida, M., Maeoka, Y., Takahashi, A., Ishiuchi, N., Osaki, Y., Sasaki, K., & Masaki, T. (2025). Effect of haemodiafiltration versus haemodialysis on vascular access patency when starting haemodialysis. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfaf017
Vancouver
Yoshida M, Maeoka Y, Takahashi A, Ishiuchi N, Osaki Y, Sasaki K, et al. Effect of haemodiafiltration versus haemodialysis on vascular access patency when starting haemodialysis. Nephrology Dialysis Transplantation. 2025. doi:10.1093/ndt/gfaf017
BibTeX
@article{Yoshida2025,
author = {Yoshida, Mahoko and Maeoka, Yujiro and Takahashi, Akira and Ishiuchi, Naoki and Osaki, Yosuke and Sasaki, Kensuke and Masaki, Takao},
title = {Effect of haemodiafiltration versus haemodialysis on vascular access patency when starting haemodialysis},
journal = {Nephrology Dialysis Transplantation},
year = {2025},
doi = {10.1093/ndt/gfaf017}
}
EUVIMED